Drugs Affecting Lipid Metabolism VIII
The Proceedings of the Eight International Symposium on Drugs Affecting Lipid Metabolism (8th D.A.L.M.) is the subject of this volume. Since the first symposium in 1960, each successive meeting has broken new ground in the field of pharmacological control of lipid levels - offering new and stimulati...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY
Springer US
1985, 1985
|
| Edition: | 1st ed. 1985 |
| Series: | Advances in Experimental Medicine and Biology
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Management of Adherence to Prescribed Medication
- Meeting Summary
- Abstracts
- Abstracts
- Author Index
- Cellular Biology of Atherosclerosis
- The Cellular Pathobiology of Atherosclerosis in 1983
- Secretory Functions of the Mononuclear Phagocyte
- Risk Factors for the Development of Premature Cardiovascular Disease
- Fate of Cholesteryl Linoleyl Ether Injected into Rats as Chylomicrons, Acetylated LDL and HDL
- Hypertriglyceridemia: Lipoprotein Receptors and Atherosclerosis
- Hypertriglyceridemia and Atherosclerosis: Analysis of an Abnormal Lipoprotein System and Potential Beneficial Effects of Triglyceride Lowering Therapy
- Apolipoproteins
- The Role of Hydrophobicity in the Structure of the Human Plasma Lipoproteins
- Metabolism of Apolipoproteins and the Metabolic Heterogeneity of Apo B in the Rat
- Proapolipoprotein A-I Metabolism in the Human and the Rat
- Isolation and Characterization of the Apolipoprotein Genes
- Apoprotein Measurements
- Use of Monoclonal Antibodies in Studies of Lipoprotein Structure and Function
- Apolipoprotein E: Receptor Binding Properties
- Apolipoprotein E Mutants, Hyperlipidemia and Arteriosclerosis
- Noninvasive Assessment of Atherosclerosis
- Noninvasive Assessment of Atherosclerosis in Nonhuman Primates
- Noninvasive Assessment of Atherosclerosis: Studies in Man
- Noninvasive Atherosclerosis Assessment for Controlled Clinical Trials
- Drugs and Diet
- Strategy, Yield and Risks of Controlling Plasma Lipids in the Primary Prevention of Coronary Heart Disease
- Mechanisms of Action of Absorbable Hypolipidemic Drugs
- Dietary Factors Affecting Lipoprotein Metabolism
- Inhibition of Cholesterol Absorption by Natural Products
- Effects of Nicotinic Acid and Its Derivatives on Lipid Metabolism and Other Metabolic Factors Related to Atherosclerosis
- HMG-CoA Reductase Inhibitors
- The Role of Phosphorylation/Dephosphorylation in the Regulation of Cholesterol 7?-Hydroxylase Activity
- Calcium Antagonists and Atherosclerosis